Delivery Order SPE2DB24D2205-SPE2DB25FEFSR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,232.56 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract with an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,188.74. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,390.30 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This competitive award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $5,405.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSRDelivery Order
The Defense Logistics Agency awarded a $1,008.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 4, 2025. This is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's DLA prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the delivery of a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This Dexcom G7 sensors delivery order supports the Defense Health Agency and other government healthcare systems' diabetes management and continuous glucose monitoring capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/1/25 |